GL1X · GenesisL1 explorer

MolNFT v1 · #32104 · protein

Structure-based design of protein tyrosine phosphatase-1B inhibitors

2BGD · Protein-tyrosine phosphatase non-receptor type 1: “Structure-based design of protein tyrosine phosphatase-1B inhibitors”. X-ray diffraction, 4 ligands (T1D, NA, CL), 2 pockets (best druggability 0.49). MolNFT v1 #32104 on GenesisL1…

PDB
2BGD
Type
protein
Length
294 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein-tyrosine phosphatase non-receptor type 1
EC
3.1.3.48
UniProt
P18031
Ligands
T1D, NA, CL, PO4
Pockets
2 · best druggability 0.49

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtein-tyrosine phosphatase non-receptor type 1 (EC 3.1.3.48)protein29437% helix, 21% strandP18031

Ligands and binding sites

  • T1D · 5-(4-methoxybiphenyl-3-yl)-1,2,5-thiadiazolidin-3-one 1,1-dioxide · ligand · chains A
  • NA · Sodium ion · metal · chains A
  • CL · Chloride ion · ion · 3 copies · chains A
  • PO4 · Phosphate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1740.490.8315T1D
2500.220.7112empty

Compared structures

  • 2BGD · Structure-based design of Protein Tyrosine Phosphatase-1B Inhibitors · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.